Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease

ClinicalTrials.gov ID: NCT01442363

Public ClinicalTrials.gov record NCT01442363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 2:54 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is designed to determine the effects of BLI-1300 ointment on perianal pain associated with active Perianal Crohn's Disease (PCD).

Study identification

NCT ID
NCT01442363
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Braintree Laboratories
Industry
Enrollment
4 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2011 (Actual)
Primary completion
Oct 2012 (Actual)
Completion
Oct 2012 (Actual)
Last update posted
Nov 13, 2023

2011 – 2012

United States locations

U.S. sites
17
U.S. states
11
U.S. cities
17
Facility City State ZIP Site status
ACRI - Phase I Anaheim California 92801 —
University of California - San Francisco San Francisco California 94115 —
Borland Groover Clinic Jacksonville Florida 32256 —
University of Maryland Baltimore Maryland 21201 —
Chevy Chase Clinical Research Chevy Chase Maryland 20815 —
Mayo Clinic Rochester Minnesota 55905 —
South Jersey Gastroenterology Marlton New Jersey 08053 —
Long Island Clinical Research Associates Great Neck New York 11021 —
New York Center for Clinical Research Lake Success New York 11042 —
Mount Sinai Medical Center New York New York 10029 —
Asheville Gastroenterology Asheville North Carolina 28801 —
UNC School of Medical Chapel Hill North Carolina 27599 —
Consultants for Clinical Research Cincinnati Ohio 45219 —
University Hospitals Case Medical Center Cleveland Ohio 44106 —
Penn State Hershey Medical Center Hershey Pennsylvania 17033 —
Medical University of South Carolina Charleston South Carolina 29425 —
Vanderbilt University Medical Center Nashville Tennessee 37212 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01442363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 13, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01442363 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →